🇺🇸 FDA
Patent

US 7329752

Carbamate compounds as 5-HT4 receptor agonists

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7329752 (Carbamate compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14